Estelle Thebaud
Overview
Explore the profile of Estelle Thebaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Godard F, Haffreingue A, Hameury F, Sarnacki S, Hervieux E, Bonnard A, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(3):e31522.
PMID: 39762635
Background And Aims: Primary lung tumors (PLTs) in children are rare, and surgery remains the key to ensure remission. Here we describe the PLTs clinical characteristics, their management, and the...
2.
Jehanno N, Corradini N, Gaspar N, Brahmi M, Valentin T, Revon Riviere G, et al.
Br J Cancer
. 2024 Oct;
131(10):1605-1612.
PMID: 39379569
Background: The Ewing Sarcoma Family of Tumors (ESFT) constitutes a group of rare malignancies, wherein approximately one-third of cases exhibit metastatic spread, particularly impacting prognosis when bone and/or bone marrow...
3.
Sprokkerieft J, van der Beek J, Spreafico F, Selle B, Thebaud E, Chowdhury T, et al.
Cancer Med
. 2024 Aug;
13(1):e6782.
PMID: 39102694
Introduction: Introduction: Renal cell carcinoma (RCC) is a very rare pediatric renal tumor. Robust evidence to guide treatment is lacking and knowledge on targeted therapies and immunotherapy is mainly based...
4.
Magnier O, Schiff I, Cristante J, Chabre O, Veloso M, Bosson J, et al.
Pediatr Blood Cancer
. 2024 May;
71(8):e31074.
PMID: 38778452
Background: Adult- and adolescent-onset neuroblastomas are rare, with no established therapy. In addition, rare pheochromocytomas may harbor neuroblastic components. This study was designed to collect epidemiological, diagnostic and therapeutic data...
5.
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles A, Thebaud E, et al.
Eur J Cancer
. 2024 Mar;
202:114001.
PMID: 38489858
Background: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this...
6.
Chaix J, Schleiermacher G, Corradini N, Andre N, Thebaud E, Gambart M, et al.
Eur J Cancer
. 2024 Feb;
201:113923.
PMID: 38377775
Introduction: Despite poor survival for patients with relapsed or refractory neuroblastoma, only 10-16% of patients are reported to be included in early phase trials. This study aimed to explore the...
7.
Fuentes C, Ouldbey Y, Orbach D, Sudour-Bonnange H, Verite C, Rome A, et al.
Pediatr Blood Cancer
. 2024 Jan;
71(4):e30864.
PMID: 38259036
Rationale: Sex cord-stromal tumors (SCST) are hormonally active and rare. The aim was to describe their endocrinological presentation and outcomes. Method: Patients (< 19 years) registered in the TGM13 registry...
8.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, et al.
J Clin Oncol
. 2024 Jan;
42(10):1135-1145.
PMID: 38190578
Purpose: Outcomes for children with relapsed and refractory high-risk neuroblastoma (RR-HRNB) remain dismal. The BEACON Neuroblastoma trial (EudraCT 2012-000072-42) evaluated three backbone chemotherapy regimens and the addition of the antiangiogenic...
9.
Gatz S, Harttrampf A, Brard C, Bautista F, Andre N, Abbou S, et al.
Clin Cancer Res
. 2023 Dec;
30(4):741-753.
PMID: 38051741
Purpose: AcSé-ESMART Arm C aimed to define the recommended dose and activity of the WEE1 inhibitor adavosertib in combination with carboplatin in children and young adults with molecularly enriched recurrent/refractory...
10.
Irtan S, Coulomb-LHermine A, Lanz C, Tabone M, Pasqualini C, Dumont B, et al.
Pediatr Blood Cancer
. 2022 Dec;
70(3):e30107.
PMID: 36453594
Aim: The number of lymph nodes (LN) that should be sampled during nephrectomy for Wilms tumour (WT) remains controversial but of utmost importance for staging purposes. The aim of this...